Pyoderma gangrenosum associated with ulcerative colitis: A case report
DOI:
https://doi.org/10.66344/jpad.27.1.2017.1035Keywords:
Pyoderma gangrenosum, ulcerative colitisAbstract
Pyoderma gangrenosum (PG) is an uncommon ulcerative cutaneous condition of heterogeneous etiology. It is characterized by rapid progression of painful necrolytic ulcer. It is associated with systemic diseases in at least 50% of patients. Diagnosis is made by exclusion of other causes of similar appearing cutaneous ulcerations including infections, malignancy, etc. In our case pyoderma gangrenosum was associated with ulcerative colitis.ÂReferences
Ahmadi S, Frank C. Pyoderma gangrenosum: uncommon presentations. Clin Dermatol. 2005;23:612-20.
Braswell SF, Kostopoulos TC. Pathophysiology of pyoderma gangrenosum (PG): an updates review. J Am Acad Dermatol. 2015;73:691-8.
Callen JP, Jackson JM. Pyoderma gangrenosum: an update. Rheum Dis Clin North Am. 2007;33:787-802.
Powell FC, Su WP, Perry HO. Pyoderma gangrenosum, classification and management. J Am Acad Dermatol. 1996;34:395-409.
Miller J, Yentzer BA, Clark A, Jorizzo JL, Feldman SR. Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol. 2010;62:646-54.
Ozdils, Akyuz F, Pinarbasi B, Demir K, Karaca C, Boztas G et al. Ulcerative colitis analysis of 116 cases. Hepatogastroenterology. 2004;51:768-70.
Downloads
Published
How to Cite
Issue
Section
License
Submission declaration
Authors retain the copyright to their work and grant the 'Journal of Pakistan Association of Dermatologists (JPAD)' the right of first publication under a Creative Commons Attribution 4.0 International (CC BY 4.0) license. This license allows others to share, adapt, and reuse the work for any purpose, including commercial use, as long as appropriate credit is given to the original authors and the journal.
By submitting a manuscript, authors confirm that the work has not been published previously (except as an abstract, lecture, or academic thesis), is not under review elsewhere, and has been approved by all authors and relevant authorities. Once accepted, the article will be openly accessible under the CC BY 4.0 license, ensuring wide dissemination and reuse with proper attribution.